143 related articles for article (PubMed ID: 32709178)
1. Ehlers-Danlos Syndrome: An Analysis of the Current Treatment Options.
Song B; Yeh P; Nguyen D; Ikpeama U; Epstein M; Harrell J
Pain Physician; 2020 Jul; 23(4):429-438. PubMed ID: 32709178
[TBL] [Abstract][Full Text] [Related]
2. Patient experience of chronic illness care and complementary integrative health use: a cross-sectional study of patients with hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS).
Guedry SE; Langley BO; Schaefer K; Hanes DA
Disabil Rehabil; 2023 Oct; 45(21):3549-3559. PubMed ID: 36222285
[TBL] [Abstract][Full Text] [Related]
3. The Analgesic Mismanagement of a Patient With Ehlers-Danlos Syndrome (Hypermobility Variant): A Case Report.
Gunendran T; Uma Dwarakanath N
Cureus; 2023 Sep; 15(9):e45713. PubMed ID: 37745744
[TBL] [Abstract][Full Text] [Related]
4. Treating pain in patients with Ehlers-Danlos syndrome : Multidisciplinary management of a multisystemic disease.
Börsch N; Mücke M; Maier A; Conrad R; Pantel JT; Sellin J; Mani K; Chopra P
Schmerz; 2024 Feb; 38(1):12-18. PubMed ID: 38189943
[TBL] [Abstract][Full Text] [Related]
5. Use of Cluster Analysis to Delineate Symptom Profiles in an Ehlers-Danlos Syndrome Patient Population.
Schubart JR; Schaefer E; Hakim AJ; Francomano CA; Bascom R
J Pain Symptom Manage; 2019 Sep; 58(3):427-436. PubMed ID: 31153935
[TBL] [Abstract][Full Text] [Related]
6. Psychological interventions for individuals with Ehlers-Danlos syndrome and hypermobility spectrum disorder: a scoping review.
Song JZ; Luong D; Feldman ECH; Tran S; Perrier L; Eubanks K; Bayley M; Kastner M; Slepian M; Munce SEP
Orphanet J Rare Dis; 2023 Aug; 18(1):254. PubMed ID: 37653505
[TBL] [Abstract][Full Text] [Related]
7. Treating pain related to Ehlers-Danlos syndrome with medical cannabis.
Dar S
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34301703
[TBL] [Abstract][Full Text] [Related]
8. Integrative medicine for hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS): a feasibility study.
Guedry SE; Langley BO; Schaefer K; Hanes DA
Disabil Rehabil; 2024 Feb; ():1-14. PubMed ID: 38353245
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes.
Schubart JR; Mills SE; Schaefer EW; Bascom R; Francomano CA
Am J Med Genet A; 2022 Apr; 188(4):1204-1213. PubMed ID: 34994522
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal Manifestations of Ehlers-Danlos Syndrome.
Yan K; Hou D; Bolden L; Laing JR; Berke G
J Voice; 2022 Nov; ():. PubMed ID: 36424241
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of no-shows to physical therapy for musculoskeletal conditions.
Bhavsar NA; Doerfler SM; Giczewska A; Alhanti B; Lutz A; Thigpen CA; George SZ
PLoS One; 2021; 16(5):e0251336. PubMed ID: 34048440
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a novel Ehlers-Danlos syndromes disability index.
Chai S; Roney P; Fagan J; Rosario ER
Front Rehabil Sci; 2024; 5():1280582. PubMed ID: 38707743
[TBL] [Abstract][Full Text] [Related]
13. Treatments related to temporomandibular disorders among patients with prevalent types of Ehlers-Danlos syndrome in Sweden.
Yekkalam N; Novo M; Wänman A
Cranio; 2024 Feb; ():1-12. PubMed ID: 38415674
[TBL] [Abstract][Full Text] [Related]
14. A qualitative study of pain and related symptoms experienced by people with Ehlers-Danlos syndromes.
Schubart JR; Mills SE; Francomano CA; Stuckey-Peyrot H
Front Med (Lausanne); 2023; 10():1291189. PubMed ID: 38235272
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicine by patients with hypermobile Ehlers-Danlos Syndrome: A qualitative study.
Doyle TA; Halverson CME
Front Med (Lausanne); 2022; 9():1056438. PubMed ID: 36590929
[TBL] [Abstract][Full Text] [Related]
16. Creatine Monohydrate as an Effective Supplement for Muscular Fatigue in an Ehlers-Danlos Patient.
Behringer CR; Afrin S
Cureus; 2024 Jun; 16(6):e61721. PubMed ID: 38846547
[TBL] [Abstract][Full Text] [Related]
17. Barriers to the Diagnosis, Care, and Management of Pediatric Patients With Ehlers-Danlos Syndrome in the United States: A Qualitative Analysis.
Black WR; Black LL; Jones JT
Glob Pediatr Health; 2023; 10():2333794X231212081. PubMed ID: 38024462
[No Abstract] [Full Text] [Related]
18. Patient and Parent Knowledge, Understanding, and Concerns After a New Diagnosis of Ehlers Danlos Syndrome.
Jones JT; Black LL; Black WR
Res Sq; 2024 Jun; ():. PubMed ID: 38946955
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatic musculoskeletal disorders.
Buchanan WW; Rainsford KD; Kean CA; Kean WF
Inflammopharmacology; 2024 Feb; 32(1):29-36. PubMed ID: 37632655
[TBL] [Abstract][Full Text] [Related]
20. Care for the patient with hip pain.
Kearns GA; Moore AK; Munger L; Seth S; Day M
Nurse Pract; 2023 May; 48(5):21-28. PubMed ID: 37458312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
